Molecular markers prognosticate the aggressiveness of papillary thyroid cancer

被引：0
作者：
Zhao, Shuang-Shuang [1 ]
Chen, Bao-Ding [1 ]
Zhang, Zheng [1 ]
机构：
[1] Jiangsu Univ, Affiliated Hosp, Dept Med Ultrasound, 438 Jiefang Rd, Zhenjiang 212001, Jiangsu, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2019年 / 12卷 / 03期
关键词：
Aggressiveness; prognosticate; thyroid cancer; papillary; molecular; TERT PROMOTER MUTATIONS; BRAF V600E MUTATION; NEEDLE-ASPIRATION-CYTOLOGY; PREOPERATIVE DIAGNOSIS; BRAF(V600E) MUTATION; RAS MUTATIONS; PAX8-PPAR-GAMMA REARRANGEMENT; CLINICOPATHOLOGICAL FEATURES; MANAGEMENT GUIDELINES; NODULES;
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Application of molecular markers in diagnosing and prognosticating thyroid cancer is of high clinical significance. These include BRAFV600E, TERT and RAS mutations, PAX8/PPAR. rearrangement, and gene expression classifier (GEC). Molecular pathogenesis of thyroid cancer has been accepted, gradually, by the elucidation of the fundamental roles of several major signaling pathways and related molecular derangements. Although most papillary thyroid cancers (PTC) occupy higher TNM stages, 10-year overall survival rates have remained high. It seems that prognosticating the aggressiveness of PTC has more weight in diagnosis. However, to date, there is no unanimous consensus regarding prognosticating the aggressiveness of PTC using molecular markers. The present review aimed to illuminate the performance of molecular markers in predicting the aggressiveness of PTC, providing unprecedented opportunities for further research and clinical development of novel treatment strategies for this cancer.
引用
收藏
页码：2121 / 2131
页数：11
相关论文
共 74 条
[11]   The role of the PAX8/PPARγ fusion oncogene in the pathogenesis of follicular thyroid cancer [J].
Eberhardt, N. L. ;
Grebe, S. K. G. ;
McIver, B. ;
Reddi, H. V. .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2010, 321 (01) :50-56
[12]   The BRAFV600E Mutation Is an Independent, Poor Prognostic Factor for the Outcome of Patients with Low-Risk Intrathyroid Papillary Thyroid Carcinoma: Single-Institution Results from a Large Cohort Study [J].
Elisei, Rossella ;
Viola, David ;
Torregrossa, Liborio ;
Giannini, Riccardo ;
Romei, Cristina ;
Ugolini, Clara ;
Molinaro, Eleonora ;
Agate, Laura ;
Biagini, Agnese ;
Lupi, Cristiana ;
Valerio, Laura ;
Materazzi, Gabriele ;
Miccoli, Paolo ;
Piaggi, Paolo ;
Pinchera, Aldo ;
Vitti, Paolo ;
Basolo, Fulvio .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (12) :4390-4398
[13]   Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology [J].
Fadda, Guido ;
Rossi, Esther Diana ;
Raffaelli, Marco ;
Pontecorvi, Alfredo ;
Sioletic, Stefano ;
Morassi, Francesca ;
Lombardi, Celestino Pio ;
Zannoni, Gian Franco ;
Rindi, Guido .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 165 (03) :447-453
[14]   Minireview: Branded from the start - Distinct oncogenic initiating events may determine tumor fate in the thyroid [J].
Fagin, JA .
MOLECULAR ENDOCRINOLOGY, 2002, 16 (05) :903-911
[15]   Evaluation of the monoclonal antibody anti-thyroperoxidase MoAb47 in the diagnostic decision of cold thyroid nodules by fine-needle aspiration [J].
Faroux, MJ ;
Theobald, S ;
Pluot, M ;
Patey, M ;
Menzies, D .
PATHOLOGY RESEARCH AND PRACTICE, 1997, 193 (10) :705-712
[16]   Genetic and biological subgroups of low-stage follicular thyroid cancer [J].
French, CA ;
Alexander, EK ;
Cibas, ES ;
Nose, V ;
Laguette, J ;
Faquin, W ;
Garber, J ;
Moore, F ;
Fletcher, JA ;
Larsen, PR ;
Kroll, TG .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (04) :1053-1060
[17]   The Associations Between RAS Mutations and Clinical Characteristics in Follicular Thyroid Tumors: New Insights from a Single Center and a Large Patient Cohort [J].
Fukahori, Michiko ;
Yoshida, Akira ;
Hayashi, Hiroyuki ;
Yoshihara, Mitsuyo ;
Matsukuma, Shoichi ;
Sakuma, Yuji ;
Koizume, Shiro ;
Okamoto, Naoyuki ;
Kondo, Tetsuo ;
Masuda, Munetake ;
Miyagi, Yohei .
THYROID, 2012, 22 (07) :683-689
[18]   ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer [J].
Garcia-Rostan, G ;
Zhao, HY ;
Camp, RL ;
Pollan, M ;
Herrero, A ;
Pardo, J ;
Ran, W ;
Carcangiu, ML ;
Costa, J ;
Tallini, G .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (17) :3226-3235
[19]   AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES-2016 UPDATE [J].
Gharib, Hossein ;
Papini, Enrico ;
Garber, Jeffrey R. ;
Duick, Daniel S. ;
Harrell, R. Mack ;
Hegedus, Laszlo ;
Paschke, Ralf ;
Valcavi, Roberto ;
Vitti, Paolo .
ENDOCRINE PRACTICE, 2016, 22 :1-60
[20]   2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer [J].
Haugen, Bryan R. ;
Alexander, Erik K. ;
Bible, Keith C. ;
Doherty, Gerard M. ;
Mandel, Susan J. ;
Nikiforov, Yuri E. ;
Pacini, Furio ;
Randolph, Gregory W. ;
Sawka, Anna M. ;
Schlumberger, Martin ;
Schuff, Kathryn G. ;
Sherman, Steven I. ;
Sosa, Julie Ann ;
Steward, David L. ;
Tuttle, R. Michael ;
Wartofsky, Leonard .
THYROID, 2016, 26 (01) :1-133
12345678